NYSE USPH

Executive leader for the strategic reimbursement of cutting edge technology in the oncology space. Effective manager of a large U.S. and international reimbursement group with measurable metrics and goals. Policy leader for payor coverage of oncology diagnostic testing for both commercial and governmental payers. Lead the development and the implementation of CLS global reimbursement and payment policy strategy across all Business Units. Accountability for the overall CBO operations, management of the reimbursement and payment policy function, and associated staff activities to implement strategic plans in order to reach established financial and other business/corporate goals. Served as the internal subject matter expert on reimbursement market and payment policy trends that impacted the business. Drove integration of reimbursement into new product development processes, including establishment of a worldwide reimbursement network to ensure proactive development and execution of CLS reimbursement strategies in all key geographies.

Director of Billing and Reimbursement for a Enzo Clinical Labs (NYSE ENZ). Effective leader of a large regional reimbursement team in the clinincal lab arenA. Helped gain payer contracts, and negotiated fee schedules for molecular and diagnostic laboratrory testing. Successfully gained state and federal approval for new and escoteric testing.

Founder and owner of a specialized physician management company, primarily based in the NYC metro area.